John G. Ullman & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Buy
45,577
+367
+0.8% +$24.1K 0.35% 74
2026
Q1
$3.22M Sell
45,210
-2,549
-5% -$201K 0.43% 67
2025
Q4
$3.92M Sell
47,759
-311
-0.6% -$24.2K 0.52% 62
2025
Q3
$3.61M Sell
48,070
-3,717
-7% -$277K 0.49% 62
2025
Q2
$3.84M Sell
51,787
-2,607
-5% -$181K 0.57% 57
2025
Q1
$4.39M Sell
54,394
-649
-1% -$55.8K 0.68% 47
2024
Q4
$4.3M Sell
55,043
-438
-0.8% -$37.2K 0.63% 57
2024
Q3
$5.21M Sell
55,481
-1,211
-2% -$102K 0.75% 45
2024
Q2
$4.42M Sell
56,692
-381
-0.7% -$31.1K 0.67% 44
2024
Q1
$5.19M Sell
57,073
-843
-1% -$70.1K 0.8% 41
2023
Q4
$4.48M Buy
57,916
+27,931
+93% +$1.96M 0.71% 48
2023
Q3
$2.04M Buy
29,985
+22,420
+296% +$1.63M 0.33% 85
2023
Q2
$615K Sell
7,565
-851
-10% -$67.9K 0.09% 122
2023
Q1
$690K Buy
+8,416
New +$601K 0.11% 113

Other funds holding GEHC

John G. Ullman & Associates's GEHC Position: Q2 2026 in Review

John G. Ullman & Associates increased its GE HealthCare (GEHC) stake by 0.81% in Q2 2026, buying an estimated $24.1K and bringing the position to 45,577 shares worth $2.92M. The position accounts for 0.35% of the portfolio, ranked #74.

John G. Ullman & Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.21M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • John G. Ullman & Associates held 45,577 shares of GE HealthCare worth $2.92M as of Q2 2026.
  • John G. Ullman & Associates bought 367 GE HealthCare shares in Q2 2026, an estimated $24.1K.
  • GE HealthCare made up 0.35% of John G. Ullman & Associates's portfolio in Q2 2026, its #74 holding.
  • John G. Ullman & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • John G. Ullman & Associates's GE HealthCare position peaked at $5.21M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on John G. Ullman & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.